Security key
92764N102
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 86,915,381
- Total 13F value
- $1,675,900,472
- Share change
- +675,901
- Put/Call ratio
- 96%
- SEC-reported price per share
- $19.28
- Number of holders
- 208
- Value change
- -$11,606,508
- Number of buys
- 129
- Number of sells
- 79
- Shares outstanding
- 168,677,036
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q3 2022
Institutions
208
Top holders
10
VIR full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
Vir Biotechnology, Inc. SEC filings
Vir Biotechnology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 92764N102
Recent filing periods:
Ownership snapshot
Top reported holders of VIR - Vir Biotechnology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
30 Jun 2022
13F
Lead comparable stake: 13%
Showing 1-6 of 15 holder rows.
Quick read
SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 13%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership
Top 5
SB INVESTMENT ADVISERS (UK) LTD
13%
BlackRock Finance, Inc.
7.6%
VANGUARD GROUP INC
4.9%
Temasek Holdings (Private) Ltd
3.3%
STATE STREET CORP
3.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SB INVESTMENT ADVISERS (UK) LTD |
13F
Company
|
13%
|
$565,858,000
22,216,644 shares
|
— | 30 Jun 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
7.6%
|
$326,313,000
12,811,690 shares
|
— | 30 Jun 2022 |
| VANGUARD GROUP INC |
13F
Company
|
4.9%
|
$208,784,000
8,197,244 shares
|
— | 30 Jun 2022 |
| Temasek Holdings (Private) Ltd |
13F
Company
|
3.3%
|
$142,697,025
5,602,553 shares
|
— | 30 Jun 2022 |
| STATE STREET CORP |
13F
Company
|
3.3%
|
$140,572,000
5,519,138 shares
|
— | 30 Jun 2022 |
| BAILLIE GIFFORD & CO |
13F
Company
|
2.3%
|
$100,119,000
3,930,852 shares
|
— | 30 Jun 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
208
Shares
86,915,381
Rows available
208
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2022 vs Q2 2022 Across Filers
Q2 2022 holders
201
Q3 2022 holders
208
Holder diff
7
| Investor | Q2 2022 Shares | Q3 2022 Shares | Share Diff | Share Chg % | Q2 2022 value | Q3 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend